Damora Therapeutics
DMRA
#5408
Rank
S$1.85 B
Marketcap
S$29.95
Share price
-4.44%
Change (1 day)
36.77%
Change (1 year)

EPS for Damora Therapeutics (DMRA)

EPS in 2026 (TTM): S-$4.86

According to Damora Therapeutics's latest financial reports the company's current EPS (TTM) is S-$4.86. In 2025 the company made an earnings per share (EPS) of S-$5.13 an increase over its 2024 EPS that were of S-$23.90.

EPS history for Damora Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.86-5.4%
2025S-$5.13-78.52%
2024S-$23.90-48.64%
2023S-$46.54-40.61%
2022S-$78.3718.54%
2021S-$66.11-73.1%
2020S-$245.74131.17%
2019S-$106.3024.59%
2018S-$85.32